Therapy Areas: Vaccines
Thailand signs deal to manufacture and supply AstraZeneca's COVID-19 vaccine
12 October 2020 -

The British and Thai governments have said that Thailand has agreed to manufacture and supply British pharmaceutical company AstraZeneca Plc's (STO: AZN)(LON:AZN) experimental COVID-19 vaccine in Thailand and other nations in the region.

Reportedly, this announcement by the British embassy in Bangkok did not specify how many doses of the vaccine candidate, AZD1222, would be distributed in Thailand. It also did not disclose the financial terms of the deal.

Thailand's Ministry of Public Health said in a separate statement that AstraZeneca is providing the potential vaccine, developed by scientists at the University of Oxford, at no profit during the pandemic and would work with Siam Bioscience to set up manufacturing facilities.

Chairman of Siam Bioscience, Satitpong Sukvimol, was quoted as saying: "With the expected technology transfer from AstraZeneca and following Thai FDA regulatory approval, the company is aiming to have the first batch of vaccines available in the middle of next year."

According to Reuters, AstraZeneca has signed several deals with companies and governments around the world to supply more than three billion doses of the vaccine as it gets closer to reporting early results of a late-stage clinical trial.



Related Headlines